These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28570663)

  • 1. Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.
    Pais R; Omosun Y; He Q; Blas-Machado U; Black C; Igietseme JU; Fujihashi K; Eko FO
    PLoS One; 2017; 12(6):e0178537. PubMed ID: 28570663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.
    Pais R; Omosun Y; Igietseme JU; Fujihashi K; Eko FO
    Front Immunol; 2019; 10():1577. PubMed ID: 31333682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H; Parnell M; Caldwell HD
    Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
    Li Z; Wang S; Wu Y; Zhong G; Chen D
    Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
    He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
    Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immune memory by a multisubunit chlamydial vaccine.
    Eko FO; Ekong E; He Q; Black CM; Igietseme JU
    Vaccine; 2011 Feb; 29(7):1472-80. PubMed ID: 21184858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
    Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
    Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
    Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
    Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.
    Lu C; Zeng H; Li Z; Lei L; Yeh IT; Wu Y; Zhong G
    Vaccine; 2012 Jan; 30(2):475-85. PubMed ID: 22079265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
    Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
    Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.
    Su H; Messer R; Whitmire W; Hughes S; Caldwell HD
    Infect Immun; 2000 Jan; 68(1):192-6. PubMed ID: 10603387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.
    Eko FO; Okenu DN; Singh UP; He Q; Black C; Igietseme JU
    Vaccine; 2011 May; 29(21):3802-10. PubMed ID: 21421002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
    Igietseme JU; Murdin A
    Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
    Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
    J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential miRNA Profiles Correlate With Disparate Immunity Outcomes Associated With Vaccine Immunization and Chlamydial Infection.
    Howard S; Richardson S; Benyeogor I; Omosun Y; Dye K; Medhavi F; Lundy S; Adebayo O; Igietseme JU; Eko FO
    Front Immunol; 2021; 12():625318. PubMed ID: 33692799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.